166 related articles for article (PubMed ID: 22522849)
21. Low-dose pulsed intravenous cyclophosphamide for severe ocular cicatricial pemphigoid in elderly patients.
Friedman J; Marcovich AL; Kleinmann G; Schattner A
Cornea; 2014 Oct; 33(10):1066-70. PubMed ID: 25014147
[TBL] [Abstract][Full Text] [Related]
22. Efficacy and adverse reactions of methotrexate in the treatment of ocular cicatricial pemphigoid: A case series study.
Shi Y; Xie C; He Y; Liu H; Zhu B; Zhu J
Medicine (Baltimore); 2018 Sep; 97(38):e12338. PubMed ID: 30235689
[TBL] [Abstract][Full Text] [Related]
23. Ocular cicatricial pemphigoid: case report.
Louie TD
J Am Optom Assoc; 1998 Mar; 69(3):153-60. PubMed ID: 9553330
[TBL] [Abstract][Full Text] [Related]
24. Intravenous immunoglobulin therapy for ocular cicatricial pemphigoid: a preliminary study.
Foster CS; Ahmed AR
Ophthalmology; 1999 Nov; 106(11):2136-43. PubMed ID: 10571350
[TBL] [Abstract][Full Text] [Related]
25. Immunosuppressive therapy in ocular cicatricial pemphigoid.
Mondino BJ; Brown SI
Am J Ophthalmol; 1983 Oct; 96(4):453-9. PubMed ID: 6353928
[TBL] [Abstract][Full Text] [Related]
26. Clinical Characteristics and Outcomes of Ocular Cicatricial Pemphigoid: A Cohort Study and Literature Review.
Fremont F; Pelissier-Suarez C; Fournié P; Porterie M; Thevenin A; Astudillo L; Paricaud K; Gualino V; Soler V; Pugnet G
Cornea; 2019 Nov; 38(11):1406-1411. PubMed ID: 31356420
[TBL] [Abstract][Full Text] [Related]
27. Comparison between intravenous immunoglobulin and conventional immunosuppressive therapy regimens in patients with severe oral pemphigoid: effects on disease progression in patients nonresponsive to dapsone therapy.
Ahmed AR; Colón JE
Arch Dermatol; 2001 Sep; 137(9):1181-9. PubMed ID: 11559214
[TBL] [Abstract][Full Text] [Related]
28. Ocular cicatricial pemphigoid, keratomycosis, and intravenous immunoglobulin therapy.
Iaccheri B; Roque M; Fiore T; Papadaki T; Mathew B; Baltatzis S; Emara B; Tokarewicz AC; Foster CS
Cornea; 2004 Nov; 23(8):819-22. PubMed ID: 15502484
[TBL] [Abstract][Full Text] [Related]
29. Influence of intravenous immunoglobulin therapy on serum levels of anti-beta 4 antibodies in ocular cicatricial pemphigoid. A correlation with disease activity. A preliminary study.
Letko E; Bhol K; Foster SC; Ahmed RA
Curr Eye Res; 2000 Aug; 21(2):646-54. PubMed ID: 11148601
[TBL] [Abstract][Full Text] [Related]
30. Ocular cicatricial pemphigoid: Methotrexate as an initial treatment?
Smichowski AM; Caputo VD; Romeo C; Rivero E; Morales NS; Casado G
Reumatol Clin (Engl Ed); 2022 Jan; 18(1):30-32. PubMed ID: 34088654
[TBL] [Abstract][Full Text] [Related]
31. Rituximab combined with conventional therapy versus conventional therapy alone for the treatment of mucous membrane pemphigoid (MMP).
Maley A; Warren M; Haberman I; Swerlick R; Kharod-Dholakia B; Feldman R
J Am Acad Dermatol; 2016 May; 74(5):835-40. PubMed ID: 26936298
[TBL] [Abstract][Full Text] [Related]
32. Treatment of ocular mucous membrane pemphigoid with immunosuppressive drug therapy.
Thorne JE; Woreta FA; Jabs DA; Anhalt GJ
Ophthalmology; 2008 Dec; 115(12):2146-2152.e1. PubMed ID: 18930554
[TBL] [Abstract][Full Text] [Related]
33. [Subconjunctival mitomycin C for the treatment of ocular cicatricial pemphigoid].
Celis Sánchez J; López Ferrando N; García Largacha M; González del Valle F; Ortiz de la Torre MJ
Arch Soc Esp Oftalmol; 2002 Sep; 77(9):501-6. PubMed ID: 12221542
[TBL] [Abstract][Full Text] [Related]
34. Successful treatment of mucous membrane pemphigoid with etanercept in 3 patients.
Canizares MJ; Smith DI; Conners MS; Maverick KJ; Heffernan MP
Arch Dermatol; 2006 Nov; 142(11):1457-61. PubMed ID: 17116836
[TBL] [Abstract][Full Text] [Related]
35. Cicatricial pemphigoid with autoantibodies against the laminin 5 gamma 2 subunit.
Dainichi T; Takeshita H; Moroi Y; Urabe K; Yoshida M; Hisamatsu Y; Komai A; Duan H; Koga T; Hashimoto T; Furue M
Eur J Dermatol; 2005; 15(3):189-93. PubMed ID: 15908306
[TBL] [Abstract][Full Text] [Related]
36. Rituximab for patients with refractory mucous membrane pemphigoid.
Le Roux-Villet C; Prost-Squarcioni C; Alexandre M; Caux F; Pascal F; Doan S; Brette MD; Soued I; Gabison É; Aucouturier F; Letestu R; Laroche L; Bachelez H
Arch Dermatol; 2011 Jul; 147(7):843-9. PubMed ID: 21422323
[TBL] [Abstract][Full Text] [Related]
37. Cost of intravenous immunoglobulin therapy versus conventional immunosuppressive therapy in patients with mucous membrane pemphigoid: a preliminary study.
Daoud Y; Amin KG; Mohan K; Ahmed AR
Ann Pharmacother; 2005 Dec; 39(12):2003-8. PubMed ID: 16264064
[TBL] [Abstract][Full Text] [Related]
38. Combined Use of Rituximab and Intravenous Immunoglobulin for Severe Autoimmune Cicatricial Conjunctivitis-An Interventional Case Series.
Steger B; Madhusudan S; Kaye SB; Stylianides A; Romano V; Maqsood SE; Harper J; Ahmad S
Cornea; 2016 Dec; 35(12):1611-1614. PubMed ID: 27661067
[TBL] [Abstract][Full Text] [Related]
39. Cicatricial pemphigoid in the upper aerodigestive tract: diagnosis and management in severe laryngeal stenosis.
Boedeker CC; Termeer CC; Staats R; Ridder GJ
Ann Otol Rhinol Laryngol; 2003 Mar; 112(3):271-5. PubMed ID: 12656421
[TBL] [Abstract][Full Text] [Related]
40. Progression of disease in ocular cicatricial pemphigoid.
Elder MJ; Bernauer W; Leonard J; Dart JK
Br J Ophthalmol; 1996 Apr; 80(4):292-6. PubMed ID: 8703876
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
